|
Volumn 63, Issue 3, 1985, Pages 485-494
|
Facts about an implantable contraceptive: Memorandum from a WHO meeting
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ETHINYLESTRADIOL;
LEVONORGESTREL;
NORGESTREL;
SILASTIC;
ABSTRACT REPORT;
ADVERSE DRUG REACTION;
ANIMAL EXPERIMENT;
CLINICAL TRIAL;
CONTRACEPTION;
DOG;
DRUG BLOOD LEVEL;
DRUG COMPARISON;
DRUG EFFICACY;
DRUG MONITORING;
DRUG TOXICITY;
FEMALE GENITAL SYSTEM;
HUMAN;
HUMAN EXPERIMENT;
INTOXICATION;
METHODOLOGY;
MOUSE;
NORMAL HUMAN;
PREVENTION;
PRIORITY JOURNAL;
RAT;
SUBCUTANEOUS DRUG ADMINISTRATION;
SUSTAINED RELEASE PREPARATION;
ANIMAL;
CONTRACEPTIVE AGENTS;
CONTRACEPTIVES, ORAL, COMBINED;
DRUG IMPLANTS;
FEMALE;
GENITALIA, FEMALE;
HUMAN;
LEVONORGESTREL;
NORGESTREL;
REPRODUCTION;
SILICONE ELASTOMERS;
|
EID: 0022376473
PISSN: 00429686
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (59)
|
References (0)
|